This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
H

ESMO 2024 Insights: Survival Impact of Adjuvant Treatment in Stage III Melanoma

By 2024 ESMO Annual Meeting Insights Hub FEATURING Hildur Helgadottir
By 2024 ESMO Annual Meeting Insights Hub FEATURING Hildur Helgadottir
92 views
September 20, 2024
0 Comments
Login to view comments. Click here to Login

2024 ESMO Annual Meeting Insights Hub: Skin Videos

18:24

New

ESMO 2024 Summary: Neoadjuvant Immunotherapy as the Future of Melano…

2024 ESMO Annual Meeting Insights Hub

A. van Akkooi

39 views
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

146 views
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

168 views
View All

Related Content

AUTOPLAY
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.7K views
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

769 views
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

733 views
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

994 views
09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

227 views
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

671 views
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

498 views
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

438 views
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

430 views
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

368 views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

406 views
03:55

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

524 views
18:28

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

388 views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

322 views
11:27

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

268 views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

320 views
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

168 views
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

260 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

526 views
07:23

Long-Term Side Effects Associated With IO Treatment vs. TT in Adjuva…

Mees Egeler

322 views